21 results on '"Buxton, Jane"'
Search Results
2. Factors associated with take-home naloxone kit usage in British Columbia: an analysis of administrative data
- Author
-
Lei, Victor, Ferguson, Max, Geiger, Rachael, Williams, Sierra, Liu, Lisa, and Buxton, Jane A.
- Published
- 2022
- Full Text
- View/download PDF
3. “Running myself ragged”: stressors faced by peer workers in overdose response settings
- Author
-
Mamdani, Zahra, McKenzie, Sophie, Pauly, Bernadette, Cameron, Fred, Conway-Brown, Jennifer, Edwards, Denice, Howell, Amy, Scott, Tracy, Seguin, Ryan, Woodrow, Peter, and Buxton, Jane A.
- Published
- 2021
- Full Text
- View/download PDF
4. The effect of depressive symptoms on pain in a substance-using population with persistent pain: a cross-sectional cohort study
- Author
-
Voon, Pauline, Choi, Jin Cheol, Hayashi, Kanna, Milloy, M-J, Buxton, Jane, and Kerr, Thomas
- Published
- 2021
- Full Text
- View/download PDF
5. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada
- Author
-
Papamihali, Kristi, Yoon, Minha, Graham, Brittany, Karamouzian, Mohammad, Slaunwhite, Amanda K., Tsang, Vivian, Young, Sara, and Buxton, Jane A.
- Published
- 2020
- Full Text
- View/download PDF
6. Overdose deaths and the COVID‐19 pandemic in British Columbia, Canada.
- Author
-
Palis, Heather, Bélair, Marc‐André, Hu, Kevin, Tu, Andrew, Buxton, Jane, and Slaunwhite, Amanda
- Subjects
COVID-19 pandemic ,DRUG overdose ,CANADIAN provinces ,OLDER people ,AGE groups - Abstract
Introduction: British Columbia (BC) declared an overdose public health emergency in 2016. Since then, BC has consistently reported the highest overdose death rates of any province in Canada. In the context of the COVID‐19 pandemic, overdose deaths in BC reached a record high in 2020. This analysis reports on changes in the profile of people who have died of overdose since BC's declaration of COVID‐19 as a public health emergency on 17 March 2020. Methods: Using BC Coroners Service data, Chi‐square tests and multivariable logistic regression were conducted to compare demographic, geographic and post‐mortem toxicology data between people who died of overdose before (17 March–31 December 2019) and after (17 March–31 December 2020) BC's declaration of COVID‐19 as a public health emergency. Results: Overdose deaths observed since 17 March 2020 (n = 1516) more than doubled those observed in the same period in 2019 (n = 744). In the adjusted logistic regression model, odds of death in the post compared to pre‐COVID‐19 period was significantly higher among males compared to females, among all older age groups compared to people aged 30–39, and was lower in public buildings compared to private residences. Discussion and Conclusions: Alongside a significant increase in overdose deaths since BC's declaration of COVID‐19 as a public health emergency, the demographic profile of people who have died of overdose has changed. Ongoing overdose prevention efforts in BC must seek to reach people who remain most isolated, including older adults, who during dual public health emergencies are facing compounded risk of preventable mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting.
- Author
-
Hayashi, Kanna, Wood, Evan, Dong, Huiru, Buxton, Jane A., Fairbairn, Nadia, DeBeck, Kora, Milloy, M.‐J., Kerr, Thomas, and Milloy, M-J
- Subjects
FENTANYL ,OPIOID epidemic ,DRUG abuse ,AT-risk people ,RESEARCH ,DRUG overdose ,INTRAVENOUS drug abuse ,CROSS-sectional method ,RESEARCH methodology ,EVALUATION research ,COMPARATIVE studies ,RESEARCH funding ,OPIOID analgesics ,DRUG abusers ,LONGITUDINAL method - Abstract
Introduction: Illicitly manufactured fentanyl continues to fuel the opioid overdose crisis throughout the USA and Canada. However, little is known about factors associated with knowingly or unknowingly using fentanyl. Therefore, we sought to identify the prevalence and correlates of suspected/known and unknown exposure to fentanyl (excluding the prescribed one) among people who inject drugs (PWID), including associated overdose risks.Methods: Data were derived from three prospective cohort studies of community-recruited people who use drugs in Vancouver, Canada in 2016-2017. Multivariable logistic regression was used to identify correlates of suspected/known exposure (i.e. urine drug screen positive and self-reporting past 3-day exposure) and unknown exposure to fentanyl (i.e. urine drug screen positive and self-reporting no past three-day exposure), respectively.Results: Among 590 PWID, 296 (50.2%) tested positive for fentanyl. Of those, 143 (48.3%) had suspected/known and 153 (51.7%) had unknown exposure to fentanyl. In multivariable analyses, using supervised injection sites and possessing naloxone were associated with both suspected/known and unknown exposure (all P < 0.05). Injecting drugs alone (adjusted odds ratio 3.26; 95% confidence interval: 1.72-6.16) was associated with known exposure, but not with unknown exposure.Discussion and Conclusions: We found a high prevalence of fentanyl exposure in our sample of PWID, with one half of those exposed consuming fentanyl unknowingly. While those exposed to fentanyl appeared more likely to utilise some overdose prevention services, PWID with suspected/known fentanyl exposure were more likely to inject alone, indicating a need for additional overdose prevention efforts for this group. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
8. Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens: a retrospective cohort study.
- Author
-
Purssell, Roy, Godwin, Jesse, Moe, Jessica, Buxton, Jane, Crabtree, Alexis, Kestler, Andrew, DeWitt, Chris, Scheuermeyer, Frank, Erdelyi, Shannon, Balshaw, Robert, Rowe, Adrianna, Cochrane, Christopher K., Ng, Benjamin, Jiang, Andy, Risi, Alessia, Ho, Vi, and Brubacher, Jeffrey R.
- Subjects
DRUG withdrawal symptoms ,NALOXONE ,FENTANYL ,DRUG overdose ,OPIOIDS ,COHORT analysis ,MEDICAL records - Abstract
When managing opioid overdose (OD) patients, the optimal naloxone regimen should rapidly reverse respiratory depression while avoiding opioid withdrawal. Published naloxone administration guidelines have not been empirically validated and most were developed before fentanyl OD was common. In this study, rates of opioid withdrawal symptoms (OW) and reversal of opioid toxicity in patients treated with two naloxone dosing regimens were evaluated. In this retrospective matched cohort study, health records of patients who experienced an opioid OD treated in two urban emergency departments (ED) during an ongoing fentanyl OD epidemic were reviewed. Definitions for OW and opioid reversal were developed a priori. Low dose naloxone (LDN; ≤0.15 mg) and high dose naloxone (HDN; >0.15 mg) patients were matched in a 1:4 ratio based upon initial respiratory rate (RR). The proportion of patients who developed OW and who met reversal criteria were compared between those treated initially with LDN or HDN. Odds ratios (OR) for OW and opioid reversal were obtained via logistic regression stratified by matched sets and adjusted for age, sex, pre-naloxone GCS, and presence of non-opioid drugs or alcohol. Eighty LDN patients were matched with 299 HDN patients. After adjustment, HDN patients were more likely than LDN patients to have OW after initial dose (OR = 8.43; 95%CI: 1.96, 36.3; p = 0.004) and after any dose (OR = 2.56; 95%CI: 1.17, 5.60; p = 0.019). HDN patients were more likely to meet reversal criteria after initial dose (OR = 2.73; 95%CI: 1.19, 6.26; p = 0.018) and after any dose (OR = 6.07; 95%CI: 1.81, 20.3; p = 0.003). HDN patients were more likely to have OW but also more likely to meet reversal criteria versus LDN patients. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada.
- Author
-
Amlani, Ashraf, McKee, Geoff, Khamis, Noren, Raghukumar, Geetha, Tsang, Erica, and Buxton, Jane A.
- Subjects
HEALTH surveys ,DRUG overdose ,DRUGS of abuse ,OPIOIDS - Abstract
Background: Fentanyl-detected illicit drug overdose deaths in British Columbia (BC) recently increased dramatically from 13 deaths in 2012 to 90 deaths in 2014, signaling an emerging public health concern. Illicit fentanyl is sold as pills or powders, often mixed with other substances like heroin or oxycodone; reports from coroners suggested that fentanyl was frequently taken unknowingly by people who use drugs. This study aimed to assess the prevalence and characteristics of fentanyl use among clients accessing harm reduction (HR) services in BC. Methods: Participants attending HR services at 17 sites across BC were invited to complete an anonymous questionnaire describing drugs they have used within the last 3 days and provide a urine sample to test for fentanyl. Data from eligible participants were analyzed using descriptive, bivariate, and multivariate statistical methods. Results: Surveys from 17 HR sites were received, resulting in analysis of responses from 242 eligible participants. Most participants used multiple substances (median = 3), with crystal meth (59 %) and heroin (52 %) use most frequently reported. Seventy participants (29 %) tested positive for fentanyl, 73 % of whom did not report using fentanyl. Controlling for age, gender, and health authority, reported use of fentanyl (odds ratio (OR) = 6.13, 95 % confidence interval (CI) = [2.52, 15.78], p < 0.001) and crystal methamphetamine (OR = 3.82, 95 % CI = [1.79, 8.63], p <0.001)use were significantly associated with fentanyl detection. Conclusions: The proportion of those testing positive who did not report knowingly using fentanyl represents a considerable public health concern. The risk of overdose among this vulnerable population highlights the need for targeted HR strategies, such as increased accessibility to naloxone, overdose education, and urine screens. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
10. Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework.
- Author
-
Nguyen, Tribesty and Buxton, Jane A.
- Subjects
- *
COVID-19 pandemic , *DRUG overdose , *DRUGS of abuse , *HEALTH policy , *PUBLIC health - Abstract
Background: Emerging evidence indicates that illicit drug overdoses are increasing throughout the COVID-19 pandemic. There is a paucity of evidence on the causative pathways for this trend, but expert opinions, commentaries, and some reviews offer theoretical underpinnings.Methods: In this rapid review, we collate the available published evidence, expert opinions, commentaries, and reviews on the unintended pathways between COVID-19 public health responses and increasing illicit drug overdoses. Using tenets of thematic analyses and grounded theory, we also offer a visual conceptual framework for these unintended pathways.Results: Our framework focuses on five particular public health responses, namely social isolation/physical distancing/quarantine; staff/resource reallocations and reductions; closures of businesses and other places of employment; border closures and transportation restrictions; and the early release of people from prisons. As argued in the literature reviewed here, these public health responses have unintentionally created increased overdose risks by producing high risk use scenarios; increased risks of relapsing; disrupted addictions services and treatment; an increasingly toxic supply of drugs; and the risk of using with lowered tolerance.Conclusions: Health care systems should respond to these pathways to mitigate the unintended consequences. Furthermore, the COVID-19 pandemic may represent an opportunity to enact proactive, progressive, and innovative solutions to an overdose crisis that will surely outlast the current pandemic. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
11. People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study.
- Author
-
Xavier, Jessica C., McDermid, Jennifer, Buxton, Jane, Henderson, Iesha, Streukens, Amber, Lamb, Jessica, and Greer, Alissa
- Subjects
- *
DRUGS of abuse laws , *SUBSTANCE abuse , *HEALTH attitudes , *QUALITATIVE research , *DRUG side effects , *HEALTH policy , *CAUSES of death , *DESCRIPTIVE statistics , *HEALTH care reform , *DRUG abusers , *GOVERNMENT regulation - Abstract
• Reliance on a toxic, illegal drug supply is a main driver of overdose in Canada. • Decriminalization was perceived as unlikely to reduce overdose deaths. • Regulation was seen as the necessary policy approach for reducing overdose deaths. • Under decriminalization, people continue to be exposed to toxic drugs. • The model of regulation is critical to the effectiveness of regulation. North America and the province of British Columbia (BC), Canada, is experiencing an unprecedented number of overdose deaths. In BC, overdose has become the leading cause of death for people between the ages of 10–59 years old. In January 2023, BC decriminalized personal possession of a number of illegal substances with one aim being to address overdose deaths through stigma reduction and promoting access to substance use services. We conducted a qualitative study to understand people who use drugs' (PWUD) perceptions of the new decriminalization policy, immediately prior to its' implementation (October-December 2022). To contextualize decriminalization within broader drug policy, we also asked PWUD what they perceived as the priority issues drug policy ought to address and the necessary solutions. Our final sample included 38 participants who used illegal drugs in the past month. We identified four themes: 1) The illicit drug supply as the main driver of drug toxicity deaths 2) Concerns about the impact of decriminalization on drug toxicity deaths 3) Views towards decriminalization as a policy response in the context of the drug toxicity crisis 4) Regulation as a symbol of hope for reducing drug toxicity deaths. From our data it became clear that many anticipated that decriminalization would have minimal or no impact on the overdose crisis. Regulation was perceived as the necessary policy approach for effectively and candidly addressing the drivers of the ongoing overdose crisis. These findings are important as jurisdictions consider different approaches to moving away from prohibition-based drug policy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Use of rapid fentanyl test strips among young adults who use drugs.
- Author
-
Krieger, Maxwell S., Goedel, William C., Buxton, Jane A., Lysyshyn, Mark, Bernstein, Edward, Sherman, Susan G., Rich, Josiah D., Hadland, Scott E., Green, Traci C., and Marshall, Brandon D.L.
- Subjects
- *
FENTANYL , *SUBSTANCE abuse , *PILLS , *HOMELESSNESS , *COCAINE - Abstract
Background: The overdose epidemic has been exacerbated by a dramatic increase in deaths involving illicitly manufactured fentanyl (IMF). Drug checking is a novel strategy to identify IMF in illicit drugs. We examined the uptake and acceptability of rapid fentanyl test strips among young adults.Methods: From May to September 2017, we recruited 93 young adults in Rhode Island who reported injecting drugs or using heroin, cocaine, or illicitly obtained prescription pills in the past 30 days. Participants were asked to test either their urine after drug use (post-consumption) or a drug sample prior to use (pre-consumption) using rapid fentanyl test strips. After a questionnaire and a brief training, participants received ten strips for their personal use and were asked to return for a one-month follow-up visit, which assessed the uptake and acceptability of the rapid strips tests and the behavioral outcomes associated with receipt of a positive test.Results: Of the 81 (87%) participants who returned for follow-up and who had complete data, the mean age was 27, 45 (56%) were male, and 37 (46%) were non-white. A total of 62 participants (77%) reported using at least one test strip. Of these, 31 (50%) received at least one positive result. A positive result was associated with older age, homelessness, heroin use, injection drug use, ever witnessing an overdose, and concern about overdose or drugs being laced with fentanyl (all p < 0.05). Receiving a positive result was significantly associated with reporting a positive change in overdose risk behavior between baseline and follow-up (p ≤ 0.01). Among all participants, 79 (98%) reported confidence in their ability to use the test strips and 77 (95%) wanted to use them in the future.Conclusions: Young adults reported high uptake and acceptability of fentanyl test strips to detect IMF in illicit drugs. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
13. An ecological study of the correlation between COVID-19 support payments and overdose events in British Columbia, Canada.
- Author
-
Richardson, Lindsey, Geddes, Cameron, Palis, Heather, Buxton, Jane, and Slaunwhite, Amanda
- Subjects
- *
DRUG overdose , *RISK assessment , *STATISTICAL correlation , *DRUG toxicity , *DESCRIPTIVE statistics , *RESEARCH , *COVID-19 , *DRUGS of abuse , *ECOLOGICAL research , *COVID-19 pandemic , *DISEASE risk factors - Abstract
• Understanding the drivers of pandemic-coincident increases in overdose is important. • Emerging research considers the potential role of income support payments. • Ecological analyses found unequal distributions overdose increases across regions. • Results found no correlation between support payments and overdose in BC. • Desynchronized payment structures may explain deviations from previous research. Pandemic income support payments have been speculatively linked to an increased incidence of illicit drug poisoning (overdose). However, existing research is limited. Collating Canadian Emergency Response Benefit (CERB) payment data with data on paramedic attended overdose and illicit drug toxicity deaths for the province of British Columbia at the Local Health Area (LHA) level, we conducted a correlation analysis to compare overdose rates before, during and after active CERB disbursement. There were 20,014,270 CERB-entitled weeks identified among residents of British Columbia for the duration of the pandemic response program. Approximately 52 % of all CERB entitled weeks in the study were among females and approximately 48 % were among males. Paramedic-attended overdoses increased uniformly across the pre-CERB, CERB and post-CERB periods, while illicit drug toxicity deaths sharply increased and then remained high over the period of the study. Correlation analyses between overdose and CERB-entitled weeks approached zero for both paramedic-attended overdoses and illicit drug toxicity deaths. These findings suggest that attributing the pandemic increase in overdose to income support payments is unfounded. Sustained levels of unacceptably high non-fatal and fatal drug poisonings that further increased at the start of the pandemic are reflective of complex pre-existing and pandemic-driven changes to overdose risk. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Illicit drug overdose deaths resulting from income assistance payments: Analysis of the 'check effect' using daily mortality data.
- Author
-
Otterstatter, Michael C., Amlani, Ashraf, Guan, Tianxiu Hugh, Richardson, Lindsey, and Buxton, Jane A.
- Subjects
- *
DRUGS of abuse , *MORTALITY , *DRUG overdose , *DRUG efficacy , *SOCIAL services , *CAUSES of death , *PUBLIC welfare , *REGRESSION analysis , *SUBSTANCE abuse , *TIME , *RETROSPECTIVE studies , *ECONOMICS - Abstract
Background: Although income assistance is an important source of support for low income individuals, there is evidence that adverse outcomes may increase when payments are disbursed on the same day for all recipients. The objective of this study was to assess the temporal patterns and causal relation between population-level illicit drug overdose deaths and income assistance payments using daily mortality data for British Columbia over a period of five years.Methods: Retrospective data on daily mortality due to illicit drug overdose, 2009-2013, were provided by the BC Coroners Service. These data were analyzed using regression models and time series tests for causality in relation to dates of income assistance payments.Results: 1343 deaths due to illicit drug overdose were reported in BC during 2009-2013; 394 occurred during cheque weeks (n=60) and 949 occurred during non-cheque weeks (n=202). Average weekly mortality due to illicit drug overdose was 40% higher during weeks of income assistance payments compared to weeks without payments (P<0.001). Consistent increases in mortality appeared the day after cheque disbursement and were significantly higher for two days, and marginally higher after 3 days, even when controlling for other temporal trends. Granger causality testing suggests the timing of cheque issue was causally linked to increased drug overdose mortality (P<0.001).Conclusions: Our findings clarify the temporal relation and causal impact of income assistance payments on illicit drug deaths. We estimate 77 avoidable deaths were attributable to the synchronized disbursement of income assistance cheques over the five year period. An important consideration is whether varying the timing of payments among recipients could reduce this excess mortality and the related demands on health and social services. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
15. Navigating Opioid Agonist Therapy among Young People who use Illicit Opioids in Vancouver, Canada.
- Author
-
Pilarinos, Andreas, Kwa, Yandi, Joe, Ronald, Thulien, Madison, Buxton, Jane A., DeBeck, Kora, and Fast, Danya
- Subjects
- *
OPIOID abuse , *COVID-19 pandemic , *BUPRENORPHINE , *CLINICAL trials , *METHADONE treatment programs , *SUBSTANCE abuse , *RESEARCH methodology , *INTERVIEWING , *FENTANYL , *FEAR , *AVOIDANCE (Psychology) , *QUALITATIVE research , *DRUG prescribing , *OPIOID analgesics , *PSYCHOLOGICAL disengagement , *THEMATIC analysis , *PHYSICIAN practice patterns , *HEROIN , *ADOLESCENCE - Abstract
Background: Opioid agonist therapy (OAT) has been shown to reduce opioid use and related harms. However, many young people are not accessing OAT. This study sought to explore how young people navigated OAT over time, including periods of engagement, disengagement, and avoidance.Methods: Semi-structured, in-depth qualitative interviews were conducted between January 2018 and August 2020 with 56 young people in Vancouver, Canada who reported illicit, intensive heroin and/or fentanyl use. Following the verbatim transcription of longitudinal interviews, an iterative thematic analysis was used to extrapolate key themes.Results: Young people contemplating OAT expressed fears about its addictiveness. Many experienced pressure from providers and family members to initiate buprenorphine-naloxone, despite a desire to explore other treatment options such as methadone. Once young people initiated OAT, staying on it was difficult and complicated by daily witnessed dosing requirements and strict rules around repeated missed doses, especially for those receiving methadone. Most young people envisioned tapering off OAT in the not-too-distant future.Conclusions: Findings underscore the importance of working collaboratively with young people to develop treatment plans and timelines, and suggest that OAT engagement and retention among young people could be improved by expanding access to the full range of OAT; updating clinical guidelines to improve access to safer prescription alternatives to the increasingly poisonous, unregulated drug supply; addressing treatment gaps arising from missed doses and take-home dosing; and providing a clear pathway to OAT tapering. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
16. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
- Author
-
Klaire, Sukhpreet, Janssen, Renée M, Olson, Karmen, Bridgeman, Jessica, Korol, Ellen E, Chu, Tim, Ghafari, Cher, Sabeti, Soha, Buxton, Jane A, and Lysyshyn, Mark
- Subjects
- *
DRUG use testing , *FENTANYL , *HARM reduction , *DRUGS of abuse , *STIMULANTS , *DRUG overdose , *RESEARCH funding , *OPIOID analgesics - Abstract
Background: Drug checking is a harm reduction strategy used to identify components of illicitly obtained drugs, including adulterants, to prevent overdose. This study evaluated the distribution of take-home fentanyl test strips to people who use drugs (PWUD) in British Columbia, Canada. The primary aim was to assess if the detection of fentanyl in opioid samples was concordant between a take-home model and testing by trained drug checking staff.Methods: Take-home fentanyl test strips were distributed at ten sites providing drug checking services from April to July 2019. The fentanyl positivity of the aggregate take-home and on-site drug checking groups were compared by class of substance tested. An administered survey assessed acceptability and behaviour change.Results: 1680 take-home results were obtained from 218 unique participants; 68% of samples (n=1142) were identified as opioids and 23% (n=382) were stimulant samples. During this period, 852 samples were tested using on-site drug checking. The fentanyl positivity of opioid samples was 90.0% for take-home samples and 89.1% for on-site samples (Difference 0.8% (95% CI -2.3% to 3.9%)). These results were not affected by previous experience with test strips. Fentanyl positivity of stimulants in the take-home group was higher than on-site (24.7% vs. 3.2%), but the study was underpowered to conduct statistical analysis on this sub-group. When fentanyl was detected, 27% of individuals reported behaviour change that was considered safer/positive. Greater than 95% of participants stated they would use fentanyl test strips again.Conclusions: Take-home fentanyl test strips used by PWUD on opioid samples can provide similar results to formal drug checking services and are a viable addition to existing overdose prevention strategies. Use of this strategy for detection of fentanyl in stimulant samples requires further evaluation. This intervention was well accepted and in some participants was associated with positive behaviour change. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
17. "It's an emotional roller coaster… But sometimes it's fucking awesome": Meaning and motivation of work for peers in overdose response environments in British Columbia.
- Author
-
Pauly, Bernadette (Bernie), Mamdani, Zahra, Mesley, Lacey, McKenzie, Sophie, Cameron, Fred, Edwards, Denice, Howell, Amy, Knott, Michael, Scott, Tracy, Seguin, Ryan, Greer, Alissa M, and Buxton, Jane A
- Subjects
- *
PUBLIC health , *HARM reduction , *COVID-19 pandemic , *DRUG overdose - Abstract
Background: The province of British Columbia (BC), Canada is amid dual public health emergencies in which the overdose epidemic declared in 2016 has been exacerbated by restrictions imposed by the Coronavirus Disease of 2019 (COVID-19) pandemic. Experiential workers, commonly known as 'peers' (workers with past or present drug use experience) are at the forefront of overdose response initiatives and are essential in creating safe spaces for people who use drugs (PWUD) in harm reduction. Working in overdose response environments can be stressful, with lasting emotional and mental health effects. There is limited knowledge about the personal meaning that experiential workers derive from their work, which serve as motivators for them to take on these often-stressful roles.Methods: This project used a community-based qualitative research design. The research was based at two organizations in BC. Eight experiential worker-led focus groups were conducted (n = 31) where participants spoke about their roles, positive aspects of their jobs, challenges they face, and support needs in harm reduction work. Transcripts were coded and analyzed using interpretative description to uncover the meaning derived from experiential work.Results: Three themes emerged from focus group data that describe the meanings which serve as motivators for experiential workers to continue working in overdose response environments: (1) A sense of purpose from helping others; (2) Being an inspiration for others, and; (3) A sense of belonging.Conclusion: Despite the frequent hardships and loss that accompany overdose response work, experiential workers identified important aspects that give their work meaning. These aspects of their work may help to protect workers from the emotional harms associated with stressful work as well as the stigma of substance use. Recognizing the importance of experiential work and its role in the lives of PWUD can help inform and strengthen organizational supports. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
18. Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada.
- Author
-
Samji, Hasina, Yu, Amanda, Wong, Stanley, Wilton, James, Binka, Mawuena, Alvarez, Maria, Bartlett, Sofia, Pearce, Margo, Adu, Prince, Jeong, Dahn, Clementi, Emilia, Butt, Zahid, Buxton, Jane, Gilbert, Mark, Krajden, Mel, and Janjua, Naveed Z.
- Subjects
- *
HEPATITIS C virus , *INTRAVENOUS drug abuse , *ANTIVIRAL agents , *FENTANYL - Abstract
Background: The majority of new HCV infections in Canada occur in people who inject drugs. Thus, while curative direct antiviral agents (DAAs) herald a promising new era in hepatitis C virus (HCV) treatment, improving the lives and wellbeing of people living with HCV (PLHCV) must be considered in the context of reducing overdose-related harms and with a syndemic lens. We measure drug-related deaths (DRDs) among HCV-negative people and PLHCV in British Columbia (BC), Canada, and the impact of potent contaminants like fentanyl on deaths.Methods: We identified DRDs among PLHCV and HCV-negative individuals from 2010 to 2018 in the BC Hepatitis Testers Cohort, a population-based dataset of ~1.7 million British Columbians comprising comprehensive administrative and clinical data. We estimated annual standardized liver- and drug-related mortality rates per 100,000 person-years (PY) and described the contribution of specific drugs, including fentanyl and its analogues, implicated in DRDs over time.Results: DRDs constituted 20.1% of deaths among PLHCV and 4.7% of deaths among HCV-negative individuals; a 4.3-fold (95% confidence interval: 4.0-4.5) difference. Drug-related mortality overtook liver-related mortality for PLHCV in 2015 and HCV-negative individuals in 2016 and rose from 241.7 to 436.5 per 100,000 PY from 2010 to 2018 amongPLHCV and from 20.0 to 57.1 per 100,000 PY for HCV-negative individuals over the same period. The proportion of deaths attributable to drugs among PLHCV and HCV-negative individuals increased from 15.1% to 26.1% and 3.1% to 8.0%, in 2010 and 2018, respectively. The proportion of DRDs attributed solely to synthetic opioids such as fentanyl averaged across both groups increased from 2.1% in 2010 to 69.6% in 2017.Conclusion: Steep drug-related mortality increases among PLHCV and HCV-negative individuals over the last decade highlight the urgent need to address overdose-related drivers and harms in these populations using an integrated care approach. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
19. Overdose and risk factors for coronavirus disease 2019.
- Author
-
Slaunwhite, Amanda Kathleen, Gan, Wen Qi, Xavier, Chloe, Zhao, Bin, Buxton, Jane A., and Desai, Roshni
- Subjects
- *
COVID-19 , *DISEASE risk factors , *CHRONIC diseases , *CHI-squared test , *CORONARY disease - Abstract
Background: There have been significant efforts to respond to the two public health emergencies of coronavirus disease 2019 (COVID-19) and overdose in British Columbia (BC), Canada. The purpose of this study was to quantify the prevalence of known risk factors associated with mortality due to COVID-19 for persons who have had a non-fatal overdose during 2015-2017 in comparison to persons who have not had an overdose.Methods: Data were extracted from the BC Provincial Overdose Cohort which includes a 20 % random sample of BC residents and persons who have had a non-fatal overdose in BC from January 2015 to December 2017. Chi-square tests and logistic regression were used to compare risk factors by overdose history.Results: Persons who had a non-fatal overdose were significantly more likely to have three (chronic pulmonary disease, diabetes, coronary heart disease) of the four known chronic conditions associated with the development of severe illness due to COVID-19 compared to persons who did not have a previous non-fatal overdose event.Conclusion: Persons who had an overdose were more likely to have several chronic conditions associated with the development of severe illness due to COVID-19. The increased likelihood of having these risk factors is reflective of the social and health inequities experienced by persons who have a history of overdose. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
20. Known fentanyl use among clients of harm reduction sites in British Columbia, Canada.
- Author
-
Karamouzian, Mohammad, Papamihali, Kristi, Graham, Brittany, Crabtree, Alexis, Mill, Christopher, Kuo, Margot, Young, Sara, and Buxton, Jane A
- Subjects
- *
FENTANYL , *HARM reduction , *DRUG overdose , *LOGISTIC regression analysis , *RESEARCH , *SUBSTANCE abuse , *RESEARCH methodology , *MEDICAL cooperation , *EVALUATION research , *COMPARATIVE studies - Abstract
Background: North America is in the midst of an opioid overdose epidemic and it is commonly suggested that exposure to fentanyl is unknown. Using a provincial survey of harm reduction site clients, we aimed to characterize known and unknown fentanyl use and their correlates among people who use drugs in British Columbia, Canada.Methods: We recruited 486 clients who were >18 years old and 316 agreed to provide a urine sample for substance use testing. Reported known fentanyl use was defined as a three-level categorical variable assessing recent (i.e., in the previous three days) fentanyl exposure: (i) known exposure; (ii) unknown exposure; and (iii) no exposure. We also assessed any exposure to fentanyl (Yes vs. No) confirmed by urinalysis. Survey data were summarized using descriptive statistics. Multinomial logistic regression and modified Poisson regression models were built to examine different correlates of exposure to fentanyl.Results: Median age of the participants was 40 (IQR: 32-49). Out of the 303 eligible participants, 38.7% (117) reported known fentanyl use, 21.7% (66) had unknown fentanyl use, and 39.6% (120) had no recent fentanyl use. In the adjusted multinomial logistic regression model and in comparison with unknown fentanyl use, recent known fentanyl use was significantly associated with self-report of methadone use (aRRR = 3.18), heroin/morphine use (aRRR = 4.40), and crystal meth use (aRRR = 2.95). Moreover, any recent exposure to fentanyl (i.e., positive urine test for fentanyl) was significantly associated with living in urban settings (aPR = 1.49), and self-reporting recent cannabis use (aPR = 0.73), crystal meth (aPR = 1.45), and heroin/morphine use (aPR = 2.48).Conclusion: The landscape of illicit opioid use is changing in BC and more people are using fentanyl knowingly. The increasing prevalence of known fentanyl use is concerning and calls for further investments in public awareness and public policy efforts regarding fentanyl exposure and risks. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
21. Correlates of take-home naloxone kit possession among people who use drugs in British Columbia: A cross-sectional analysis.
- Author
-
Moustaqim-Barrette, Amina, Papamihali, Kristi, Crabtree, Alexis, Graham, Brittany, Karamouzian, Mohammad, and Buxton, Jane A.
- Subjects
- *
DRUG abuse , *CROSS-sectional method , *NALOXONE , *POISSON regression , *RISK perception - Abstract
Introduction: In response to North America's opioid crisis, access to naloxone has increased. However, our understanding of the correlates of possessing a naloxone kit is limited. This study seeks to determine the prevalence and correlates of kit possession among people who use drugs (PWUD) in British Columbia (BC) Canada.Methods: This analysis used cross-sectional survey data collected in 2018 from 27 harm reduction sites in BC. Descriptive statistics and Poisson regression with robust error variance were used to examine factors associated with naloxone kit possession.Results: Overall, 70.7% (n = 246) of the total sample (n = 348) reported having a naloxone kit. Having a kit was significantly associated with self-reported opioid use in comparison with non-opioid use (Adjusted Prevalence Ratio (APR): 2.39; 95% CI: 1.33-4.32). Those reporting 'injection' as their preferred drug administration method were also more likely to possess a kit compared to those that predominantly preferred inhalation, smoking, or snorting (APR: 2.39; 95% CI: 1.25-4.58). Urbanicity, age, gender, and having regular housing were not significantly associated with possessing a kit.Conclusions: This study is the first to examine naloxone kit possession across geographies, including non-urban areas. Lower kit possession among those that preferred inhaling, smoking or snorting drugs may reflect misconceptions around overdose risk of non-injection drug administration. Our study supports the need for enhanced awareness around the risk of opioid overdose with non-injection administration and suggests a need for comprehensive public health messaging that aims to address overdose risk and response. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.